Drug name - Ixempra Kit

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7312237 R-PHARM US LLC Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases Aug, 2024

(1 year, 10 months from now)

US7312237

(Pediatric)

R-PHARM US LLC Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases Feb, 2025

(2 years from now)

Drugs and Companies using IXABEPILONE ingredient

Treatment: Use of ixabepilone in combination with capecitabine in treatment of metastasis breast cancer

Dosage: INJECTABLE;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
15MG/VIAL INJECTABLE;INTRAVENOUS Prescription
45MG/VIAL INJECTABLE;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.